Fideliomed logo — Intelligent Diagnostics for timely clinical decision and tar...

Fideliomed

Intelligent Diagnostics for timely clinical decision and targeted therapy in primary care

Founded 2022 Italy Italy 5 employees Grant Total: $20.00K

General Information

Company Name Fideliomed
Founded Year 2022
Location Italy Italy +2
Employees 5
Funding Stage Grant
Social

Get notified when Fideliomed moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Fideliomed

Fideliomed is a streamlined diagnostic platform that utilizes AI-powered decision support to enable early disease diagnosis and targeted therapy in primary care. Launched in 2022 and headquartered in Italy, the company recently secured a €20.00K grant investment from eAwards Italia on 19 September 2023. With a focus on intelligent diagnostics for timely clinical decision and targeted therapy, Fideliomed is positioned to make significant strides in revolutionizing primary care processes.

Taxonomy: diagnostic platform, AI-powered decision support, early disease diagnosis, targeted therapy, primary care, iron deficiency, anemia management

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 19 Sep 2023

FAQ About Fideliomed

Intelligent Diagnostics for timely clinical decision and targeted therapy in primary care
Fideliomed was founded in 2022.
Fideliomed is headquartered in Italy.
Fideliomed has approximately 5 employees.
Fideliomed has completed 1 funding round, raising a total of $20.00K. The latest funding stage is Grant.

Don't just browse. Track.

Signal Tracker monitors Fideliomed and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy